Acesso livre
Acesso livre

Destaques

Opinião do Dr. Eric Topol | Por que uma única dose de vacina após infecção por Covid-19 deveria ser suficiente para se considerar uma vacinação completa.

22 Fev, 2022 | 15:42h

Why one-shot after a Covid-19 infection should suffice to be considered fully-vaxxed – The Guardian

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Metanálise mostra que há baixo risco de uma segunda reação alérgica a vacinas de mRNA contra SARS-CoV-2 em pacientes que apresentaram tal reação na primeira dose.

22 Fev, 2022 | 15:40h

Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis – JAMA Internal Medicine

 

Comentário no Twitter

 

[Preprint] Um estudo observacional de larga escala feito no Chile mostrou que a CoronaVac (vacina de SARS-CoV-2 inativado) foi associada com efetividade de 74,5% contra infecção, 91% contra internação e 93,8% contra admissão em UTI em crianças de 6 a 16 anos de idade.

22 Fev, 2022 | 15:38h

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Children and Adolescents: A Large-Scale Observational Study – Preprints with The Lancet

Comentário: Full schedule of CoronaVac vaccine shown to be highly effective in children – News Medical

Reino Unido revela planos para “conviver com a COVID”.

22 Fev, 2022 | 15:37h

UK unveils game plan for ‘living with COVID’ – CIDRAP

Ver também:

All you need to know about the end of Covid rules in England – The Guardian

‘Living with Covid’ strategy could do more harm than good, say businesses and unions – The Guardian

Por que a subvariante Ômicron se dissemina mais rápido que a original?

22 Fev, 2022 | 15:35h

Why does the Omicron sub-variant spread faster than the original? – Nature

Conteúdos relacionados:

Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant.

Covid-19: What do we know about omicron sublineages?

We regret to inform you that we are now discussing subvariants – Vox

Sudden rise of more transmissible form of Omicron catches scientists by surprise.

Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?

[Preprint] Study suggests SARS-CoV-2 Omicron subvariants BA.2 is even more transmissible than the original variant.

BA.2 is like Omicron’s sister. Here’s what we know about it so far – The Conversation

Consumo de vegetais crus e cozidos e risco de doença cardiovascular: um estudo com 400.000 adultos no UK Biobank.

22 Fev, 2022 | 15:34h

Raw and Cooked Vegetable Consumption and Risk of Cardiovascular Disease: A Study of 400,000 Adults in UK Biobank – Frontiers in Nutrition

Comentários:

Eating veggies won’t protect your heart, study says, but critics disagree – CNN

Study Finds No Heart Benefit From Veggies. Nutritionists Disagree – HealthDay

Eating vegetables does not protect against cardiovascular disease, finds large-scale study – Frontiers

Estudo randomizado | Em pacientes com Covid-19 leve a moderada e comorbidades, o tratamento com ivermectina não reduziu o risco de progressão da doença.

22 Fev, 2022 | 14:55h

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial – JAMA Internal Medicine

Comentários:

Ivermectin doesn’t prevent severe disease from Covid-19, new study finds – CNN

Ivermectin futile for mild to moderate COVID-19, study finds – CIDRAP

Conteúdos relacionados:

Case Series: Toxic effects from ivermectin use associated with prevention and treatment of Covid-19.

Long-term consequences of the misuse of ivermectin data.

Ivermectin: How false science created a Covid ‘miracle’ drug.

Fraudulent ivermectin studies open up new battleground between science and misinformation.

The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

Ivermectin: Cochrane’s most talked about review so far, ever. Why?

Flawed ivermectin preprint highlights challenges of COVID drug studies.

Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

Why was a major study on ivermectin for covid-19 just retracted?

RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19.

Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease”.

Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.

Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19

Revisão da literatura e metanálise | Efetividade das vacinas contra COVID-19 no mundo real.

22 Fev, 2022 | 14:53h

Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis – International Journal of Infectious Diseases

Diretrizes rápidas da ESCMID para avaliação e tratamento de “long COVID”.

22 Fev, 2022 | 14:52h

ESCMID rapid guidelines for assessment and management of long COVID – Clinical Microbiology and Infection

Conteúdos relacionados:

ERS statement on Long COVID-19 follow-up.

Proposed subtypes of long-Covid and their respective potential therapies.

EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.

Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

Revisão | “Long COVID”: sequelas pós-agudas de COVID-19 com foco cardiovascular.

22 Fev, 2022 | 14:49h

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus – European Heart Journal

Comunicado de imprensa: Review highlights impact of Long COVID on cardiovascular system – University of Oxford

Conteúdos relacionados:

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.